Skip to content

Using ultrasound to guide pain relief during minimally invasive spine surgery

A randomized controlled trial comparing ultrasound-guided erector spinae plane block versus local anesthesia for pain control and perioperative outcomes in percutaneous transforaminal endoscopic discectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN69505916
Enrollment
60
Registered
2025-04-23
Start date
2021-05-20
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ultrasound-guided erector spinae plane block in percutaneous transforaminal endoscopic discectomy Surgery

Interventions

Intervention Group (ESPB): The ultrasound-guided erector spinae plane block (ESPB) is administered once prior to surgery. No repeated dosing is involved. Control Group (LA): Local anesthesia is simil

Sponsors

Dehua County Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
32 Years to 56 Years

Inclusion criteria

Inclusion criteria: 1. Invalid conservative treatment for twelve weeks 2. Patients complaining of lower back and lower limb pain or numbness and motor weakness due to LDH 3. Symptoms associated with pre-operative MRI and CT scans 4. None of the patients had a prior history of percutaneous foraminal surgery 5. Imagological examination showing single-segmental LDH without accompanying thickening and calcification of posterior longitudinal ligament and ligamentum flavum

Exclusion criteria

Exclusion criteria: 1. Patients with surgical contraindication 2. Multiple segments of disc herniation, vertebral infection or tumor 3. Lumbar spondylolisthesis, obvious degenerative deformities, instability, and scoliosis 4. Substantial diseases of important organs 5. Patients who withdrew their participation

Design outcomes

Primary

MeasureTime frame
1. Intraoperative VAS scores (Visual Analog Scale) at foraminoplasty, annulus fibrosus operation, and end of surgery. 2. Measured using VAS during the procedure.

Secondary

MeasureTime frame
1. Mean arterial pressure (MAP) and heart rate (HR) at four perioperative time points (T0–T3) 2. Operation time, intraoperative blood loss, length of hospital stay 3. Modified Macnab criteria at 3-month follow-up 4. Pre- and postoperative VAS and ODI scores at 3 and 6 months 5. Reoperation willingness on post-op Day 1

Countries

China

Contacts

Public ContactXiaoting Zheng
1540635330@qq.com+86 15377986263

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026